Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Neurology
|
September 25, 1999
Do early seizures beget epilepsy?
W Theodore, C G Wasterlain
Neurology
|
February 1, 1974
Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations
C G Wasterlain
Neurology
|
October 1, 1976
Effects of neonatal status epilepticus on rat brain development
C G Wasterlain
Neurology
|
February 1, 1991
Hypothermia does not explain MK-801 neuroprotection in a rat model of neonatal hypoxic-ischemic encephalopathy
H Hattori, C G Wasterlain
Neurology
|
May 20, 1999
Is the devil we know the lesser of two evils? Vigabatrin and visual fields
R Sankar, C G Wasterlain
Neurology
|
May 1, 1993
Dextromethorphan and its combination with phenytoin facilitate kindling
K W Thompson, C G Wasterlain
Neurology
|
March 1, 1978
Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat
C G Wasterlain, A H Lockwood, M Conn
Neurology
|
March 29, 2001
Neurologic manifestations of disseminated infection with Mycobacterium abscessus
D S Liebeskind, N Ostrzega, C G Wasterlain, et al.
Neurology
|
May 1, 1989
Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat
H Hattori, A M Morin, P H Schwartz, et al.
Neurology
|
November 1, 1993
Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia
C G Wasterlain, L M Adams, P H Schwartz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Neurology
|
September 25, 1999
Do early seizures beget epilepsy?
W Theodore, C G Wasterlain
Neurology
|
February 1, 1974
Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations
C G Wasterlain
Neurology
|
October 1, 1976
Effects of neonatal status epilepticus on rat brain development
C G Wasterlain
Neurology
|
February 1, 1991
Hypothermia does not explain MK-801 neuroprotection in a rat model of neonatal hypoxic-ischemic encephalopathy
H Hattori, C G Wasterlain
Neurology
|
May 20, 1999
Is the devil we know the lesser of two evils? Vigabatrin and visual fields
R Sankar, C G Wasterlain
Neurology
|
May 1, 1993
Dextromethorphan and its combination with phenytoin facilitate kindling
K W Thompson, C G Wasterlain
Neurology
|
March 1, 1978
Chronic inhibition of brain protein synthesis after portacaval shunting. A possible pathogenic mechanism in chronic hepatic encephalopathy in the rat
C G Wasterlain, A H Lockwood, M Conn
Neurology
|
March 29, 2001
Neurologic manifestations of disseminated infection with Mycobacterium abscessus
D S Liebeskind, N Ostrzega, C G Wasterlain, et al.
Neurology
|
May 1, 1989
Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat
H Hattori, A M Morin, P H Schwartz, et al.
Neurology
|
November 1, 1993
Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia
C G Wasterlain, L M Adams, P H Schwartz, et al.
Page
of 2